Clinical Trial

An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated July 31, 2025 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the remission effect and safety of intravenous injection of METR-NK cells as adjuvant therapy on bone marrow suppression in patients with ovarian cancer after chemotherapy
Trial Details
NCT Number NCT07096583
Lead Sponsor Anhui Provincial Cancer Hospital
Collaborators: Anhui Kecheng intelligent health technology Co., LTD
Conditions Ovary Cancer
Enrollment 20 participants
Start Date 2025-07-07
Primary Completion 2026-07-30 (estimated)
Study Completion 2027-07-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-31